新型冠状病毒肺炎后综合征（post⁃covid⁃19 syndrome，PCS）是部分患者在遭受新冠肺炎后持 续出现一些不能用其他诊断来解释的包括呼吸、运动、心身等功能障碍的后遗症，康复治疗的根本目的在 于最大限度帮助患者恢复与重建缺失功能，提升生活质量。传统康复形式患者依从性差且花费巨大，因 此如何降低疾病负担，提高 PCS 治愈率成为亟待解决的关键难题。近年来，数字疗法以其良好的安全性、 依从性以及经济性为PCS 患者治疗提供了新的方法，也成为了提高PCS 治疗效果的潜在候选者。当前，早 期临床研究已经报道了数字疗法单一及联合治疗在 PCS 治疗中的独特优势。因此，本文旨在通过对数字 疗法在 PCS 中的临床试验及应用进展进行综述，并对其安全性和有效性进行探讨，以期为临床应用提供 一定参考。

Post⁃covid⁃19 syndrome（PCS）is a condition in which some patients suffer from persistent respiratory，motor，psychosomatic and other dysfunctional sequelae that cannot be explained by other diagnoses. Traditional forms of rehabilitation are poorly adhered to and costly. Therefore，how to reduce the burden of disease and increase the cure rate of PCS has become a key challenge to be addressed. In recent years，digital therapies， with their excellent safety，compliance and affordability，have opened new opportunities for the treatment of PCS patients and are potential candidates for improving the outcome of PCS treatment. Currently，early clinical studies have reported the unique benefits of digital therapies in the treatment of PCS in both single and combination thera⁃ pies. Taken together，the aim of this article is to review the recent clinical trials and applications of digital thera⁃ pies in PCS and to discuss their safety and efficacy in order to provide some reference for clinical application.